ID
15641
Beschrijving
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Month 12 2nd cycle Trial Medication
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Trefwoorden
Versies (1)
- 06-06-16 06-06-16 -
Geüploaded op
6 juni 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Month 12 2nd cycle Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Month 12 2nd cycle Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Beschrijving
Trial Medication RQG
Beschrijving
Date of Administration
Datatype
date
Alias
- UMLS CUI [1,1]
- C1533734
- UMLS CUI [1,2]
- C0011008
Beschrijving
Trial Medication: Dose administered
Datatype
float
Maateenheden
- mg
Alias
- UMLS CUI [1]
- C3174092
Beschrijving
Trial Medication: Batch No
Datatype
text
Alias
- UMLS CUI [1]
- C3641829
Beschrijving
Expiration
Datatype
date
Alias
- UMLS CUI [1]
- C3669020
Beschrijving
Trial Medication: Reason if less than 12 mg
Datatype
text
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0392360
Similar models
Month 12 2nd cycle Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
C0947611 (UMLS CUI [1,2])
C1550373 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1705848 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])